Attached files
file | filename |
---|---|
8-K - FORM 8-K - Hill-Rom Holdings, Inc. | c94413e8vk.htm |
EX-10.4 - EXHIBIT 10.4 - Hill-Rom Holdings, Inc. | c94413exv10w4.htm |
EX-10.2 - EXHIBIT 10.2 - Hill-Rom Holdings, Inc. | c94413exv10w2.htm |
EX-10.1 - EXHIBIT 10.1 - Hill-Rom Holdings, Inc. | c94413exv10w1.htm |
Exhibit 99.1
CONTACT INFORMATION
Investor Relations
Contact: | Blair A. (Andy) Rieth, Jr., Vice President, Investor
Relations, Corporate Communications & Global Brand
Development |
|
Phone: | 812-931-2199 Email: andy.rieth@hill-rom.com |
Media Relations
Contact: | Lauren Green-Caldwell, Director, Corporate Communications & Public Relations |
|
Phone: | 812-934-8692 Email: lauren.green-caldwell@hill-rom.com |
HILL-ROM APPOINTS JOHN J. GREISCH
AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
BATESVILLE, Ind. January 7, 2010 Hill-Rom Holdings, Inc. (NYSE: HRC) today announced that
John J. Greisch, 54, has been appointed President and Chief Executive Officer of the company,
effective January 8, 2010. He succeeds Peter H. Soderberg, who previously announced his intention
to retire. Greisch also has been appointed to the companys Board of Directors.
Greisch brings over 30 years of international operations and financial leadership experience to
Hill-Rom. He spent the past seven years at Baxter International, Inc. (NYSE: BAX), a global
diversified health care company with expertise in medical devices, pharmaceuticals and
biotechnology. Most recently, Greisch served as Baxters President, International Operations, and
before that, as Chief Financial Officer. Greisch also served as President of Baxters BioScience
division.
Our Board of Directors is delighted to welcome John Greisch to Hill-Rom, said Rolf A. Classon,
Hill-Roms Chairman of the Board. With his proven leadership and successful track record, John
will help us capitalize on Hill-Roms market-leading position and global expansion opportunities
that will drive future growth. We are confident that John and our strong management team will
continue to execute our strategy to the benefit of our customers and our shareholders.
Commenting on his appointment, Greisch said, This is an exciting opportunity for me. Hill-Rom has
a great brand and strong market positions and I am proud to have the opportunity to lead the
company to the next level of success. With the companys diverse product portfolio and focus on
innovation, I am confident that we can continue to bring market-leading innovative solutions to
patients and caregivers around the world and across the care continuum.
As previously announced, Soderberg will continue to advise the company on product and service
innovation initiatives on a part-time basis. As planned, in connection with Greischs appointment,
Soderberg has stepped down from the companys Board.
We want to thank Peter for his dynamic and visionary leadership over the past four years, which
has led us to spin off our funeral services business and positioned Hill-Rom as the focused and
leading medical technology company it is today. We appreciate his willingness to continue his
involvement with the company, which will ensure a smooth transition, concluded Classon.
In his most recent role as President, International Operations at Baxter, Greisch achieved double
digit annual increases in revenues and profits. He doubled the companys business in China and led
expansion efforts into new markets in Asia, the Middle East, Russia and Eastern/Central Europe.
Prior to joining Baxter, Greisch was President and CEO of FleetPride Corporation. Before that, he
spent 11 years at The Interlake Corporation, a diversified global manufacturing company, serving in
a variety of roles, including Group President, Chief Financial Officer, and President of its
European operations based in London. Greisch currently serves on the Board of Directors for
TomoTherapy, Inc. (NASDAQ: TOMO). He also serves on the Board of Directors of Childrens Memorial
Hospital Foundation and on the Board of Trustees of the John G. Shedd Aquarium. Greisch received a
bachelors degree in Business Administration from Ohios Miami University and a masters degree in
Management from Northwestern Universitys J.L. Kellogg Graduate School of Management.
Conference Call and Webcast
The company will sponsor a conference call and audio webcast for the investing public at 9 a.m.
EST,
8 a.m. CST, today. The webcast will be available at the following link
http://ir.hill-rom.com/eventdetail.cfm?eventid=76343 or on the Hill-Rom website at
http://ir.hill-rom.com/events.cfm. The call will be archived on the companys website through
January 6, 2011 for those who are unable to view it live. A replay audio of the call is also
available through January 14, 2010 at 888-203-1112 (719-457-0820 International). Code 6243002 is
needed to access the replay.
ABOUT HILL-ROM
Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related
services for the health care industry, including patient support systems, safe mobility and
handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical
conditions, medical equipment rentals, and information technology solutions. Hill-Roms
comprehensive product and service offerings are used by health care providers across the health
care continuum and around the world in hospitals, extended care facilities and home care settings
to enhance the safety and quality of patient care.
Hill-Rom...enhancing outcomes for patients and their caregivers.
www.hill-rom.com
DISCLOSURE REGARDING FORWARD LOOKING STATEMENTS
Certain statements in this press release contain forward-looking statements, within the meaning of
the Private Securities Litigation Reform Act of 1995, regarding the Companys future plans,
objectives, beliefs, expectations, representations and projections. The Company has tried,
wherever possible, to identify these forward-looking statements using words such as intend,
anticipate, believe, plan, encourage, expect, may, goal, become, pursue,
estimate, strategy, will, projection, forecast, continue, accelerate, promise,
increase, higher, lower, reduce, improve, expand, progress, potential or the
negative of those terms or other variations of them or by comparable terminology. The absence of
such terms, however, does not mean that the statement is not forward-looking. It is important to
note that forward-looking statements are not guarantees of future performance, and the Companys
actual results could differ materially from those set forth in any forward-looking statements.
Factors that could cause actual results to differ from forward-looking statements include but are
not limited to: the Companys dependence on its relationships with several large group purchasing
organizations, whether the Companys new products are successful in the marketplace, impacts of
health care reform, compliance with federal health care programs, collections of accounts
receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product
liability or other claims, failure of the Companys announced strategic initiatives and
restructuring and realignment activities to achieve expected growth, future restructuring or
realignment activities, efficiencies or cost reductions, adverse consequences resulting from the
recent spin-off of the funeral service business, failure of the Company to execute its acquisition
and business alliance strategy through the consummation and successful integration of acquisitions
or entry into joint ventures or other business alliances, increased costs or unavailability of raw
materials, labor disruptions, the ability to retain executive officers and other key personnel,
liquidity of auction rate securities and certain tax-related matters. For a more in depth
discussion of these and other factors that could cause actual results to differ from those
contained in forward-looking statements, see the discussions under the heading Risk Factors in
the Companys Annual Report on Form 10-K for the period ended September 30, 2009, which was
previously filed with the Securities and Exchange Commission. The Company assumes no obligation to
update or revise any forward-looking statements.